Published on in Vol 24, No 7 (2022): July

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/38243, first published .
The Effect of Tailored, Daily, Smartphone Feedback to Lifestyle Self-Monitoring on Weight Loss at 12 Months: the SMARTER Randomized Clinical Trial

The Effect of Tailored, Daily, Smartphone Feedback to Lifestyle Self-Monitoring on Weight Loss at 12 Months: the SMARTER Randomized Clinical Trial

The Effect of Tailored, Daily, Smartphone Feedback to Lifestyle Self-Monitoring on Weight Loss at 12 Months: the SMARTER Randomized Clinical Trial

Original Paper

1School of Nursing, University of Pittsburgh, Pittsburgh, PA, United States

2School of Public Health, University of Pittsburgh, Pittsburgh, PA, United States

3School of Rehabilitation Sciences, University of Pittsburgh, Pittsburgh, PA, United States

4School of Medicine, University of Utah, Salt Lake City, UT, United States

Corresponding Author:

Lora E Burke, MPH, PhD

School of Nursing

University of Pittsburgh

3500 Victoria St

Pittsburgh, PA, 15261

United States

Phone: 1 412 779 0555

Email: lbu100@pitt.edu


Background: Self-monitoring (SM) is the centerpiece of behavioral weight loss treatment, but the efficacy of smartphone-delivered SM feedback (FB) has not been tested in large, long-term, randomized trials.

Objective: The aim of this study was to establish the efficacy of providing remote FB to diet, physical activity (PA), and weight SM on improving weight loss outcomes when comparing the SM plus FB (SM+FB) condition to the SM-only condition in a 12-month randomized controlled trial. The study was a single-site, population-based trial that took place in southwestern Pennsylvania, USA, conducted between 2018 and 2021. Participants were smartphone users age ≥18 years, able to engage in moderate PA, with a mean BMI between 27 and 43 kg/m2.

Methods: All participants received a 90-minute, one-to-one, in-person behavioral weight loss counseling session addressing behavioral strategies, establishing participants’ dietary and PA goals, and instructing on use of the PA tracker (Fitbit Charge 2), smart scale, and diet SM app. Only SM+FB participants had access to an investigator-developed smartphone app that read SM data, in which an algorithm selected tailored messages sent to the smartphone up to 3 times daily. The SM-only participants did not receive any tailored FB based on SM data. The primary outcome was percent weight change from baseline to 12 months. Secondary outcomes included engagement with digital tools (eg, monthly percentage of FB messages opened and monthly percentage of days adherent to the calorie goal).

Results: Participants (N=502) were on average 45.0 (SD 14.4) years old with a mean BMI of 33.7 (SD 4.0) kg/m2. The sample was 79.5% female (n=399/502) and 82.5% White (n=414/502). At 12 months, retention was 78.5% (n=394/502) and similar by group (SM+FB: 202/251, 80.5%; SM: 192/251, 76.5%; P=.28). There was significant percent weight loss from baseline in both groups (SM+FB: –2.12%, 95% CI –3.04% to –1.21%, P<.001; SM: –2.39%, 95% CI –3.32% to –1.47%; P<.001), but no difference between the groups (–0.27%; 95% CI –1.57% to 1.03%; t =–0.41; P=.68). Similarly, 26.3% (66/251) of the SM+FB group and 29.1% (73/251) of the SM group achieved ≥5% weight loss (chi-square value=0.49; P=.49). A 1% increase in FB messages opened was associated with a 0.10 greater percent weight loss at 12 months (b=–0.10; 95% CI –0.13 to –0.07; t =–5.90; P<.001). A 1% increase in FB messages opened was associated with 0.12 greater percentage of days adherent to the calorie goal per month (b=0.12; 95% CI 0.07-0.17; F=22.19; P<.001).

Conclusions: There were no significant between-group differences in weight loss; however, the findings suggested that the use of commercially available digital SM tools with or without FB resulted in a clinically significant weight loss in over 25% of participants. Future studies need to test additional strategies that will promote greater engagement with digital tools.

Trial Registration: Clinicaltrials.gov NCT03367936; https://clinicaltrials.gov/ct2/show/NCT03367936

J Med Internet Res 2022;24(7):e38243

doi:10.2196/38243

Keywords



Obesity is associated with several chronic diseases [1,2]. Obesity prevalence in the United States exceeds 42.4% and disproportionately affects racial and ethnic minority groups [3,4].

The gold standard for weight loss treatment is standard behavioral treatment (SBT), which includes reduced energy intake, increased energy expenditure, and in-person, group-based behavioral counseling plus feedback (FB) on self-monitoring (SM) from a trained interventionist [5-7]. However, SBT is difficult to implement on a large scale to reach populations most in need of treatment [8]. There is a critical need for more affordable, scalable, less burdensome, and efficacious treatments for weight loss [4].

The cornerstone of SBT is SM with interventionist FB [9-12]. A meta-regression demonstrated that SM use was the strongest predictor of efficacy in a weight loss intervention [13]. The highest efficacy was reported in a study in which SM was combined with another self-regulation technique [14], such as FB. Several studies have examined strategies to enhance sustained engagement in SM, including use of digital tools [5,11,12,15-20].

However, despite improvements in SM (eg, advancing from paper to digital tools), 2 issues persist: individuals still find SM burdensome [21] and SM adherence declines over time, which is associated with poorer weight loss outcomes [11,15,17-19,21-28]. Advances in mobile technology provide opportunities to enhance interventions targeting SM, expand their reach, and prevent decline in adherence. Delivering real-time FB to SM can reinforce behavior change [29] and partially replace in-person sessions [30,31]. The addition of wearable activity trackers [32] and smart scales [33] that synchronize data with a smartphone eliminates the need to manually record physical activity (PA) and weight, reducing burden and increasing adherence [19,34,35].

We previously examined the effect of providing FB to dietary SM and PA; however, the hardware and software used were rudimentary compared to today’s technology [16]. Despite these limitations, remotely delivered FB messages enhanced SM adherence and improved weight loss [29,36]. These results and significant mobile technology enhancements provided groundwork for the expanded algorithm and FB intervention used in this trial, SMARTER [23].

SMARTER was a 2-group randomized controlled trial that enrolled 502 adults with random assignment to either (1) SM alone (n=251) or (2) SM+FB (n=251) and examined the efficacy of the approaches. We examined short-term outcomes at 6 months with 86% retention that demonstrated that both groups lost a significant percent weight from baseline (SM+FB: –3.16%, P<.001; SM: –3.20%, P<.001) but found no significant between-group difference (P=.94) [37]. We hypothesized that the SM+FB group would show greater percent weight loss at 12 months compared to the SM group. For the SM+FB group, we also report the percent of FB messages opened and association with weight change and daily calorie goal adherence. We hypothesized that a greater number of FB messages that were opened would result in greater weight loss and adherence to the calorie goal.


Ethical Considerations

We published the study protocol and design previously [23]. The study was approved by the Institutional Review Board for Human Protection at the University of Pittsburgh (#19060112) and registered on ClinicalTrials.gov (NCT03367936). We informed all participants of screening procedures prior to obtaining consent and obtained in-person informed consent for the intervention study.

Recruitment

Recruitment, conducted in the greater community surrounding Pittsburgh, PA, commenced in August 2018 and ended in March 2020. The intervention trial was completed in April 2021. Both online and in-person methods were used. Initially, interested individuals who were regular smartphone users completed surveys and a 5-day food diary in which they needed to record at least 700 calories of food intake per day to ensure that they could SM. Once deemed eligible, individuals had an in-person assessment to verify weight and height for BMI measures. Inclusion criteria were BMI between 27 and 43 kg/m2, completion of a 5-day electronic food diary, and ability to engage in moderate PA. Exclusion criteria were needing supervision of diet or PA, pregnancy, serious mental illness (eg, schizophrenia), alcohol abuse or eating disorder, and current weight loss treatment [23].

Randomization

After completing the intervention consent, research staff used a randomization software program to determine group assignment that was generated using minimization with stratification by gender (male or female) and race (Black or non-Black) with equal allocation to the 2 treatment conditions (please see the CONSORT [Consolidated Standards of Reporting Trials] diagram in Figure 1). All randomized participants were included in the final analyses. We used Wadden's conservative approach for imputing missing weight data assuming that there was a weight gain.

Key staff (BB, IL) who conducted the assessments were not blinded to the treatment assignment, whereas all other personnel and investigators, including the statisticians, (LEB, SMS, ZB, BP, JK, JC, MC, IWP, YW, and MBC) were blinded to assignment. Since participants were informed of both treatment conditions, they could not be blinded.

Figure 1. CONSORT (Consolidated Standards of Reporting Trials) diagram for the SMARTER trial.
View this figure

Intervention

Behavioral Intervention

The intervention was grounded in behavioral change theory with an emphasis on Kanfer’s self-regulation theory that posits that SM is central to behavior change and includes FB tailored to the SM data. At baseline, all participants had a 90-minute, one-on-one, in-person intervention session with a dietitian on the core concepts of SBT followed by a demonstration of the Fitbit app to enter foods eaten for SM of diet, a Fitbit activity tracker to monitor PA, and a smart scale for daily self-weighing. Use of the investigator-developed SMARTER app, which was used only for random retrieval of FB messages from the message library and delivery of messages to the participant’s smartphone, was demonstrated to the SM+FB participants, so they could view the prompt icon for the FB messages and open the app to read the message. Participants used their own smartphones; the other SM devices (Fitbit activity tracker and commercially available smart scale) were provided by the study.

Dietary Intake

Participants used the Fitbit app to view food nutrient values, app-generated subtotals, and the daily intake summaries. The calorie goal was determined from baseline body weight (women: 1200 kcal for <200 lb or 1500 kcal ≥200 lb; men: 1500 kcal for <200 lb or 1800 kcal for ≥200 lb) and individualized as needed [23]. Fat gram goals approximated 25% of the calorie goal (eg, 33 or 42 grams per day for females).

Physical Activity

All participants monitored PA using a wrist-worn activity tracker, the Fitbit Charge 2, synced with their smartphone. Staff instructed participants to increase their PA gradually, primarily by walking, and to aim for 150 minutes per week by 12 weeks [38]. Once at goal, they were encouraged to add 10 minutes per week until they reached 300 minutes per week [23]. All aerobic activities counted toward PA goals. The Fitbit database stored total steps, sedentary minutes, and active minutes.

Weight

All participants were instructed to weigh daily on the study-provided smart scale that transmitted weight data to their smartphone and study database.

Feedback Messages

The FB algorithm was programmed on the study’s server and used real-time synced SM data to send the FB message up to 3 times per day. Individuals in the SM+FB group received up to 3 FB messages per day on their smartphone during waking hours tailored to the most recent SM data and addressing caloric as well as fat and added-sugar intake daily and PA every other day. Weekly weight FB was based on whether self-weighing occurred and the amount or rate of weight change. FB messages addressed 1 behavior at a time. The participant received a prompt that there was a new FB message on the smartphone. If the FB message was not opened within 1 hour of being sent, the SMARTER icon prompt and message disappeared; if the message was opened, the participant could save it for future review. More details on the FB messages and study infrastructure for message delivery are available elsewhere [23,37].

Engagement with SM tools was a crucial component of the intervention, as the algorithm used the SM data to determine an appropriate FB message. If the participant did not SM, FB messages were sent encouraging SM. After 2 weeks of missing SM data, staff sent an email query about technical issues and encouraged SM. Additional details on the algorithm and FB messages are published elsewhere [23]. The message library was changed at least monthly to avoid participant desensitization to FB [29]. Individuals in the SM group did not receive FB messages or staff emails. Further details of all intervention components and the algorithm driving the FB messages have been published elsewhere [23].

Outcomes

Assessments

Both in-person and web-based assessments were used initially, and the in-person assessments were performed at the Clinical Research Center in the School of Nursing at the University of Pittsburgh. At in-person assessments, participants (in light clothing and bare feet) stood on a Tanita scale and body fat analyzer at baseline, 6 months, and 12 months. Percent lean and fat mass were also collected; however, after March 16, 2020 (ie, the beginning of the COVID-19 pandemic shutdown), we collected 12-month weight data remotely from the participants’ study-provided scales, which assessed only weight and percent fat mass. Staff contacted participants to instruct them to dress in clothing as in the baseline assessment and report their weight, which was also captured electronically [23]. At 12 months, of the 502 participants, 189 (37.7%) had in-person weights, 205 (40.8%) had remote weights, and 108 (21.5%) had missing weights. Smart scale weights recorded within 2 weeks of 6- or 12-month assessments were used for imputation of missing weights. If no weight was recorded by the smart scale, a 0.01 kg/day weight gain was assumed from last available scale weight value [39]. Cardiometabolic measures are reported in Multimedia Appendix 1 (Figures S1-S6). Participants were compensated for completing the 6- and 12-month assessments regardless of mode of conduct, in-person or remotely.

Feedback Messages

The monthly percentage of FB messages opened over the 12 months are expressed as the number of FB messages opened over the total number of FB messages sent in 30-day increments and multiplied by 100%.

Adherence to the Study-Defined Calorie Goal

The monthly percentage of days adherent to the calorie goal (defined as between 85% and 115% of daily calorie goal) among participants meeting the dietary SM goal (≥50% daily calorie goal) was calculated as follows:

Number of days meeting calorie goal per month / Number of days meeting dietary SM criteria per month × 100%

Statistical Analysis

The planned total sample size for this randomized controlled trial was determined as 530 (265 per treatment group), allowing for a statistical power of 0.80 to detect effect sizes (standardized mean differences, d) as small as d=0.301 for the mean percent weight changes at 6 and 12 months between the SM-only and SM + FB groups when using linear mixed modeling with linear contrasts at a Bonferroni-adjusted significance level of P=.025 and for at most 20% attrition [23]. Due to the COVID-19 pandemic, recruitment was stopped in March 2020 with 502 randomized participants (251 per treatment arm). With this reduced sample size, slightly larger small-to-medium effect sizes of d=0.309 would still be detectable with 0.80 power at an adjusted significance level of P=.025, allowing for up to 20% attrition.

Continuous variables are summarized as mean and SD, and descriptive statistics for categorical variables are reported as counts with percentages. Appropriate group comparative analyses were performed on participant descriptors and outcome variables at baseline by randomized treatment assignment [37]. The effect of treatment assignment on percent weight change over 12 months was examined using linear mixed modeling following intention to treat. Models included a random intercept and unstructured variance-covariance matrix for the repeated assessments, supported by Akaike information and Bayesian information criteria. The base model included fixed effects for time (baseline vs 6 months and 12 months), group (SM+FB vs SM alone), and group by time interaction. Sensitivity analyses were performed among completers only and using inverse probability weighting for dropout by 12 months with age, race, and baseline as predictors.

The effect of the percentage of FB messages opened on percent weight change from baseline to 12 months for the SM+FB group was analyzed using univariate linear regression. Additionally, the associations of monthly percentages of days adherent to the calorie goal with treatment assignment and monthly percentages of FB messages opened were analyzed using separate linear mixed models with random intercept and slope for the total sample and for the SM+FB group, respectively. We conducted sensitivity analyses on the treatment effects on monthly percentages of days adherent to the calorie goal over 12 months in the total sample and on the associations between monthly percentages of FB messages opened and monthly percentages of days adherent to the calorie goal in the SM+FB group for the varying monthly percentage of days with sufficient dietary SM data (data not shown). Here, we report the results using days with ≥50% of the calorie goal recorded or ≥15 of 30 days with sufficient dietary SM data.

Model assessment (ie, residual analyses with influence diagnostics) was performed for each fitted model; sensitivity analyses were conducted for outlying or influential observations and to explore the effect of the COVID-19 pandemic on the efficacy of treatment assignment on percent weight change (data not shown). All analyses were performed using SAS version 9.4 (SAS Institute).


Baseline Characteristics

Most participants were White (414/502, 82.5%), female (399/502, 79.5%) and on average 45.0 (SD 14.4) years old. Sociodemographic, clinical, and psychosocial characteristics, as well as primary outcome measurements at baseline, were similar between the treatment groups [37].

Retention

At 12 months, the overall retention was 78.5% (394/502). Retention was similar by treatment condition, with SM+FB at 80.5% (202/251) and SM at 76.5% (192/251; X2=1.18; P=.28).

Percent and Absolute Weight Change

Figures 2 and 3 illustrate the results from linear mixed modeling for the effect of treatment assignment on weight loss and percentage of weight loss over 12 months. On average, both groups had statistically significant weight loss over 12 months (b6 months=–2.94, 95% CI –3.70 to –2.19; b12 months=–2.34, 95% CI –3.10 to –1.59; F= 61.46; P<.001). The trajectory of weight change over time was similar between groups (bgroup × 6 months=0.09, 95% CI –0.97 to –1.16; bgroup × 12 months=0.36, 95% CI –0.70 to –1.43; F=0.24; P=.79), and there were no significant overall treatment effects on weight change (bgroup=–0.32; 95% CI –3.04 to 2.40; F=0.02; P=.90). There was a significant percent weight loss from baseline in both groups (SM+FB: –2.12%, 95% CI –3.04% to –1.21%, P<.001; SM: –2.39%, 95% CI –3.32% to –1.47%, P<.001), but no difference between the groups (–0.27%; 95% CI –1.57% to 1.03%; t=–0.41; P=.68). The percentages of participants who lost ≥5% weight from baseline to 12 months were similar between the SM+FB (66/251, 26.3%) and SM (73/251, 29.1%) arms (Χ2=0.49; P=.49). Based on sensitivity analyses using inverse probability weighting, there was no significant difference in percent weight change at 12 months in the SM+FB arm (mean –3.57%, SD 20.16) and the SM arm (mean –3.53%, SD 19.94; t=0.07; P=.95). Additional analyses among completers showed no significant treatment effects on percent weight change at 12 months (SM+FB: mean –3.54%, SD 7.16; SM mean: –3.58%, SD 7.06; t= –0.07; P=.95). For the total sample, mean weight change in kilograms at 12 months was mean –2.16 kg (SD 0.27). There was no significant difference in weight change in kilograms at 12 months in the SM+FB arm (mean –1.98 kg, SD 0.38) or the SM arm (mean –2.34, SD 0.38; 2-sample t test=0.67; P=.50).

Analyses without outliers had results similar to the full-sample results. There were no significant effects for the COVID-19 pandemic on the relationship of treatment with weight change over time.

Figure 2. Effect of treatment assignment on weight change.
View this figure
Figure 3. Effect of treatment assignment on percent weight change.
View this figure

Feedback Messages Opened

In the SM+FB arm, the median percentage of FB messages opened from baseline to 12 months was 42.19% (461/1026; q1: 234/597, 39.20%; q3: 728/1095, 66.48%) and ranged from 1.28% (14/78) to 93.70% (1026/1095). Figure 4 displays the association of the percentage of FB messages opened and percent weight change at 12 months. A 1% increase in FB messages opened was associated with a 0.10 greater percent weight loss at 12 months (b=–0.10; 95% CI –0.13 to –0.07; t=–5.90; P<.001).

Figure 4. The associations between percentages of feedback messages opened and percent weight change at 12 months.
View this figure

Percentage of Days Adherent to the Calorie Goal

Figure 5 illustrates the change in monthly percentage of days adherent to the calorie goal by treatment group over 12 months using the criteria of recording ≥50% of the calorie goal 15 days per month. The monthly percentage of days adherent to the calorie goal declined nonlinearly in both groups. Overall, the percentage of days adherent to the calorie goal was greater in the SM+FB group than in the SM group (bgroup=4.43; 95% CI 0.41-8.45; F=4.67; P=.03). The rate of decline in percentage of days adherent to the calorie goal was slower in the SM+FB arm than the SM arm over 12 months (bgroup× time-linear=–1.98, 95% CI –3.03 to –0.93, F=13.71, P<.001; bgroup× time-quadratic=0.14, 95% CI 0.06-0.22, F=11.04, P<.001).

Figure 5. Effect of treatment assignment on percentage of days adherent to the calorie goal over 12 months.
View this figure

Figure 6 illustrates the change in monthly percentages of FB messages opened and monthly percentages of days adherent to the calorie goal over 12 months and their association in the SM+FB group, respectively. In general, monthly percentages of FB messages opened (btime-linear=–8.34, 95% CI –9.91 to –6.78, F=110.26, P<.001; btime-quadratic=0.54, 95% CI 0.27-0.81, F=15.07, P<.001; btime-cubic=–0.02, 95% CI –0.04 to –0.009, F=10.63, P=.001) and monthly percentages of days adherent to the calorie goal declined nonlinearly over 12 months (btime-linear=–3.37, 95% CI –5.29 to –1.45, F=11.93, P=.001; btime-quadratic=0.44, 95% CI 0.10-0.79, F=6.26, P=.01; btime-cubic=–0.02, 95% CI –0.04 to 0.001, F=3.62, P=.06), with a greater percentage of FB messages opened being associated with higher adherence to the calorie goal as shown in Figure 7 (bFB=0.12; 95% CI 0.07 to 0.17; F=22.19; P<.001). There was no significant interaction between the percentage of FB messages opened and the polynomial time effects.

Figure 6. Change in monthly percentages of feedback messages opened and days adherent to the calorie goal in SM+FB over 12 months.
View this figure
Figure 7. The associations between monthly percentages of feedback messages opened and days adherent to the calorie goal in SM+FB over 12 months.
View this figure

Principal Results

We conducted a trial of a scalable, remotely delivered, behavioral weight loss intervention and tested the efficacy of a custom-developed, theoretically based, smartphone app that provided real-time FB remotely to reinforce diet, PA, and self-weighing behaviors. We observed a small but significant percent weight change from baseline to 12 months with no significant difference between the groups, suggesting the FB provided no additional benefit beyond SM. Our findings suggest that it is feasible to deliver a 12-month, remotely delivered intervention for weight loss to a large sample even with COVID-19 pandemic restrictions. The percent weight losses observed (equivalent to an absolute weight change of 2.0-2.5 kg) were less than what is usually reported in studies of in-person group counseling or online coaching [40-42] but not different from other small trials that tested digital interventions with limited human interaction [43]. A systematic review of eHealth interventions reported similar weight losses (1.4 to 2.7 kg) [44] at postintervention [45].

In this paper, we report initial app engagement findings, specifically the number of times participants opened the app to SM or read FB messages. Our study demonstrated that without personal interaction, engagement declined to the point that it interfered with the intervention delivery. Although the FB message system worked in theory, the declining adherence to SM created a lack of data for the algorithm to select a FB message. Sending an email message after 2 weeks without evident SM might have been too long to wait to prompt re-engagement, and a phone call might have been more effective; however, we were trying to increase the study scalability. The COVID-19 shutdown ended all in-person interactions including assessments, which might have affected engagement.

We measured engagement by the percentage of FB messages opened, which was reflective of dietary SM adherence. Overall, approximately 40% (461/1026, 42.19%; IQR 45.30) of the FB messages were opened with a very wide range of 1.28% (14/78) to 93.70% (14/78) in our study. Although this is less than ideal, engagement was equal (or greater) than the 41% to 60% rate of engagement that others have reported [46-48] in mobile health studies. A recent literature review emphasized the challenge of initial and sustained engagement in mobile health studies [49]. Considering the completely remote intervention with minimal to no in-person contact, our findings are encouraging but indicate a continued need to improve sustained engagement in SM [50].

Comparison With Prior Work

There was greater adherence to the calorie goal in the SM+FB group compared to the SM group, and a greater number of FB messages opened was associated with a greater percent weight loss in the SM+FB group, suggesting that when messages were opened, the FB messages reinforced behavior changes related to food selection. These findings are similar to those in the SMART trial which showed that the personal data assistant + FB group had better adherence to the dietary goals and was the only 1 of the 3 study groups that had a significant within-group weight loss over 24-months. In SMART, adherence to SM strongly predicted weight loss at all time points [17,29,49].

The study algorithm and FB message library for SMARTER were significantly expanded from the earlier SMART trial; however, these improvements did not compensate for the absence of the 16 in-person group sessions that were part of the SMART trial, suggesting that some form of interpersonal interaction may be needed to augment mobile health interventions. Recent studies have reported similar findings [40,42]. For example, Thomas et al [40] demonstrated that providing a monthly in-person weigh-in to accompany 5-minute skills training videos achieved weight losses comparable to the gold standard of frequent in-person group sessions over the 18-month trial. Similarly, Amagai et al’s [49] literature review suggested that coaching to provide social support is an important strategy to improve engagement.

The comparison group in SMARTER received the same treatment components (ie, a one-to-one, in-person intervention session at baseline and digital tools for SM) and achieved very similar weight loss without receiving any prompts or reminders to SM. The intent of this comparative intervention was to determine the effectiveness of the approach that thousands of individuals are using by purchasing apps and tracking devices. These results suggest that some individuals who receive individual guidance at baseline with goals for diet and PA and encouragement to SM can achieve a clinically significant weight loss under their own direction.

Both groups used the Fitbit Charge 2 for tracking diet and PA. The Fitbit provided graphical FB on dietary intake (total calories consumed and “burned”) and a weekly summary of PA; thus, the SM-only group received some automatic FB if they were syncing their device to their phone. Although this FB could be reinforcing for some individuals, it lacked the personalized component that the SMARTER FB provided since the SMARTER messages were tailored to SM data entered at that time, were positive in tone, and often provided suggestions. However, due to the lower-than-expected engagement with SM, many individuals did not open (and therefore receive) enough messages.

A recent pilot study that used a 2 × 2 factorial design provides some insights into FB (counselor-crafted vs pre-scripted [51]) and group sessions (yes or no). Participants in the group sessions were more engaged in SM and lost more weight than did those not offered group sessions; however, the group that received pre-scripted, modular FB had significantly greater weight loss than did the group that received the counselor-crafted FB while there was no consistent difference in their treatment engagement. It is not known why the group that received briefer FB lost more weight; the longer FB sent weekly was possibly perceived as burdensome. The authors and other researchers suggested that the mechanisms underlying FB are poorly defined and that the amount, timing, frequency, and framing are just a few of the dimensions that need to be further studied [52-54].

Several recent weight loss intervention studies have examined an array of digital strategies to enhance adherence to SM while reducing components of the gold standard SBT; however, several had small samples, conducted brief interventions, and had small weight losses [26,43,55]. Despite these limitations, results showed promise for further study of approaches to enhance SM adherence (eg, counseling phone calls [26] or weekly emails with structured lessons [43]). The cumulative evidence makes it difficult to determine which intervention components can be most effective in producing clinically meaningful weight loss. Specifically, it is difficult to ascertain how much of the human interventionist component can be replaced to make weight loss treatments scalable to a broader reach and lower operational costs. This critical gap in the evidence needs to be addressed in future studies, so we can broaden our reach to the millions who need weight loss treatment, particularly those who do not have access to existing clinical and commercial weight loss programs.

Study Strengths

There are several strengths to our study: a large sample size, a rigorous randomized design with a comparable control group, a retention rate higher than that reported by shorter and similar studies [56], use of validated measures, defined adherence metrics, and an objective measure of FB messages opened. The theory-based intervention was expanded from a previously tested and efficacious FB system. Additional strengths include using an extensive remote screening system and, born of necessity due to the COVID pandemic, pivoting to a remotely delivered, objective assessment protocol with minimal data loss.

Study Limitations

Limitations include recruitment of fewer males and minorities than targeted, which limits generalizability. The retention was slightly lower than the targeted 80%. The metric of FB messages opened does not necessarily equate to the actual number of FB messages read.

Conclusions

The SMARTER trial delivered customized, real-time FB to participants based on SM data and capitalized on the use of available digital technology to provide personal weight management support without ongoing human counseling. This approach is scalable, as it reduces cost and participant burden while increasing reach to those without access to SBT or who do not wish to participate in an in-person program. We hypothesized that participants in the SM+FB group would have greater weight loss than those in the SM group at 12 months; however, weight loss outcomes were similar. Our results suggest that the addition of FB to SM did not make a significant between-group difference in weight loss outcomes; however, those who remained engaged and opened more FB messages had better calorie goal adherence and weight outcomes. Moreover, one-fourth and almost one-third of each group achieved clinically significant weight loss, suggesting that for a portion of participants, the SM component of the intervention was efficacious.

Considering the unrelenting prevalence of obesity, there is a critical need for scalable interventions that can reach those most at risk and with the least resources. The evidence supports standalone, scalable digital interventions, yet the crucial challenge is the development of digital tools that will keep users engaged long enough to see positive, sustainable outcomes. In advancing the digital aspects, we also need to identify the most efficacious personal interaction components that best augment and support sustained SM and lifestyle change. Obesity is a complex, multifactorial, chronic condition that requires ongoing support and an array of treatment options that will accommodate for the diverse needs of those seeking treatment.

Acknowledgments

This research was supported by grants from the National Institutes of Health (NIH) to LEB (#R01-HL131583), JK (#R01-HL131583S), and JC (#F31-HL15627), and a grant from the University of Pittsburgh Clinical Translational Science Institute to Dr Steve Reis (#UL1-TR001857).

The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the National Heart, Lung, and Blood Institute.

The authors would also like to acknowledge the participants who enrolled in the study and the time they gave to our research.

Authors' Contributions

LEB wrote the manuscript, SMS and ZB conducted the data analyses, and MBC contributed guidance and consultation throughout the writing process. All authors read and approved the manuscript.

Conflicts of Interest

None declared.

Multimedia Appendix 1

Cardiometabolic measures.

DOCX File , 191 KB

Multimedia Appendix 2

CONSORT-eHEALTH checklist (V 1.6.2).

PDF File (Adobe PDF File), 108 KB

  1. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation 2014 Jun 24;129(25 Suppl 2):S102-S138 [FREE Full text] [CrossRef] [Medline]
  2. LeBlanc ES, Patnode CD, Webber EM, Redmond N, Rushkin M, O'Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the us preventive services task force. JAMA 2018 Sep 18;320(11):1172-1191. [CrossRef] [Medline]
  3. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017-2018. NCHS Data Brief 2020 Feb(360):1-8 [FREE Full text] [Medline]
  4. Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. state-level prevalence of adult obesity and severe obesity. N Engl J Med 2019 Dec 19;381(25):2440-2450. [CrossRef] [Medline]
  5. Butryn ML, Webb V, Wadden TA. Behavioral treatment of obesity. Psychiatr Clin North Am 2011 Dec;34(4):841-859 [FREE Full text] [CrossRef] [Medline]
  6. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007 Oct;107(10):1755-1767. [CrossRef] [Medline]
  7. Loveman E, Frampton GK, Shepherd J, Picot J, Cooper K, Bryant J, et al. The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review. Health Technol Assess 2011 Jan;15(2):1-182 [FREE Full text] [CrossRef] [Medline]
  8. Foley P, Steinberg D, Levine E, Askew S, Batch BC, Puleo EM, et al. Track: A randomized controlled trial of a digital health obesity treatment intervention for medically vulnerable primary care patients. Contemp Clin Trials 2016 Dec;48:12-20 [FREE Full text] [CrossRef] [Medline]
  9. Weed LL. Medical records that guide and teach. N Engl J Med 1968 Mar 21;278(12):652-7 concl. [CrossRef] [Medline]
  10. Burke LE, Wang J, Sevick MA. Self-monitoring in weight loss: a systematic review of the literature. J Am Diet Assoc 2011 Jan;111(1):92-102 [FREE Full text] [CrossRef] [Medline]
  11. Burke LE, Conroy MB, Sereika SM, Elci OU, Styn MA, Acharya SD, et al. The effect of electronic self-monitoring on weight loss and dietary intake: a randomized behavioral weight loss trial. Obesity (Silver Spring) 2011 Feb;19(2):338-344 [FREE Full text] [CrossRef] [Medline]
  12. Patel ML, Wakayama LN, Bennett GG. Self-Monitoring via Digital Health in Weight Loss Interventions: A Systematic Review Among Adults with Overweight or Obesity. Obesity (Silver Spring) 2021 Mar;29(3):478-499. [CrossRef] [Medline]
  13. Michie S, Abraham C, Whittington C, McAteer J, Gupta S. Effective techniques in healthy eating and physical activity interventions: a meta-regression. Health Psychol 2009 Nov;28(6):690-701. [CrossRef] [Medline]
  14. Carver CS, Scheier MF. Control theory: a useful conceptual framework for personality-social, clinical, and health psychology. Psychol Bull 1982 Jul;92(1):111-135. [Medline]
  15. Burke LE, Sereika SM, Music E, Warziski M, Styn MA, Stone A. Using instrumented paper diaries to document self-monitoring patterns in weight loss. Contemp Clin Trials 2008 Mar;29(2):182-193 [FREE Full text] [CrossRef] [Medline]
  16. Burke LE, Styn MA, Glanz K, Ewing LJ, Elci OU, Conroy MB, et al. SMART trial: A randomized clinical trial of self-monitoring in behavioral weight management-design and baseline findings. Contemp Clin Trials 2009 Nov;30(6):540-551 [FREE Full text] [CrossRef] [Medline]
  17. Burke LE, Styn MA, Sereika SM, Conroy MB, Ye L, Glanz K, et al. Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med 2012 Jul;43(1):20-26 [FREE Full text] [CrossRef] [Medline]
  18. Conroy MB, Yang K, Elci OU, Gabriel KP, Styn MA, Wang J, et al. Physical activity self-monitoring and weight loss: 6-month results of the SMART trial. Med Sci Sports Exerc 2011 Aug;43(8):1568-1574 [FREE Full text] [CrossRef] [Medline]
  19. Zheng Y, Terry MA, Danford CA, Ewing LJ, Sereika SM, Goode RW, et al. Experiences of Daily Weighing Among Successful Weight Loss Individuals During a 12-Month Weight Loss Study. West J Nurs Res 2018 Apr;40(4):462-480. [CrossRef] [Medline]
  20. Eysenbach G. Medicine 2.0: social networking, collaboration, participation, apomediation, and openness. J Med Internet Res 2008;10(3):e22 [FREE Full text] [CrossRef] [Medline]
  21. Burke LE, Swigart V, Warziski TM, Derro N, Ewing LJ. Experiences of self-monitoring: successes and struggles during treatment for weight loss. Qual Health Res 2009 Jun;19(6):815-828 [FREE Full text] [CrossRef] [Medline]
  22. Burke LE, Sereika S, Choo J, Warziski M, Music E, Styn M, et al. Ancillary study to the PREFER trial: a descriptive study of participants' patterns of self-monitoring--rationale, design and preliminary experiences. Contemp Clin Trials 2006 Feb;27(1):23-33. [CrossRef] [Medline]
  23. Burke LE, Sereika SM, Parmanto B, Beatrice B, Cajita M, Loar I, et al. The SMARTER Trial: Design of a trial testing tailored mHealth feedback to impact self-monitoring of diet, physical activity, and weight. Contemp Clin Trials 2020 Apr;91:105958 [FREE Full text] [CrossRef] [Medline]
  24. Burke LE, Zheng Y, Ma Q, Mancino J, Loar I, Music E, et al. The SMARTER pilot study: Testing feasibility of real-time feedback for dietary self-monitoring. Prev Med Rep 2017 Jun;6:278-285 [FREE Full text] [CrossRef] [Medline]
  25. Turk MW, Elci OU, Wang J, Sereika SM, Ewing LJ, Acharya SD, et al. Self-monitoring as a mediator of weight loss in the SMART randomized clinical trial. Int J Behav Med 2013 Dec;20(4):556-561 [FREE Full text] [CrossRef] [Medline]
  26. Butryn ML, Godfrey KM, Martinelli MK, Roberts SR, Forman EM, Zhang F. Digital self-monitoring: Does adherence or association with outcomes differ by self-monitoring target? Obes Sci Pract 2020 Apr;6(2):126-133 [FREE Full text] [CrossRef] [Medline]
  27. Burke LE, Warziski M, Starrett T, Choo J, Music E, Sereika S, et al. Self-monitoring dietary intake: current and future practices. J Ren Nutr 2005 Jul;15(3):281-290. [Medline]
  28. Burnier M, Schneider MP, Chioléro A, Stubi CL, Brunner HR. Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisions. J Hypertens 2001 Feb;19(2):335-341. [CrossRef] [Medline]
  29. Ambeba EJ, Ye L, Sereika SM, Styn MA, Acharya SD, Sevick MA, et al. The use of mHealth to deliver tailored messages reduces reported energy and fat intake. J Cardiovasc Nurs 2015;30(1):35-43. [CrossRef] [Medline]
  30. Rao G, Kirley K. The future of obesity treatment. JAMA Intern Med 2013 Jan 28;173(2):111. [CrossRef]
  31. Rao G, Kirley K. The future of obesity treatment: comment on "Integrating technology into standard weight loss treatment: a randomized controlled trial". JAMA Intern Med 2013 Jan 28;173(2):111-112. [CrossRef] [Medline]
  32. Balbim GM, Marques IG, Marquez DX, Patel D, Sharp LK, Kitsiou S, et al. Using Fitbit as an mHealth Intervention Tool to Promote Physical Activity: Potential Challenges and Solutions. JMIR Mhealth Uhealth 2021 Mar 01;9(3):e25289 [FREE Full text] [CrossRef] [Medline]
  33. Zheng Y, Klem ML, Sereika SM, Danford CA, Ewing LJ, Burke LE. Self-weighing in weight management: a systematic literature review. Obesity (Silver Spring) 2015 Feb;23(2):256-265. [CrossRef] [Medline]
  34. Ross KM, Qiu P, You L, Wing RR. Week-to-week predictors of weight loss and regain. Health Psychol 2019 Dec;38(12):1150-1158 [FREE Full text] [CrossRef] [Medline]
  35. Zheng Y, Burke LE, Danford CA, Ewing LJ, Terry MA, Sereika SM. Patterns of self-weighing behavior and weight change in a weight loss trial. Int J Obes (Lond) 2016 Sep;40(9):1392-1396. [CrossRef] [Medline]
  36. Burke LE, Styn MA, Sereika SM, Conroy MB, Ye L, Glanz K, et al. Using mHealth technology to enhance self-monitoring for weight loss: a randomized trial. Am J Prev Med 2012 Jul;43(1):20-26 [FREE Full text] [CrossRef] [Medline]
  37. Burke LE, Sereika SM, Parmanto B, Bizhanova Z, Kariuki JK, Cheng J, et al. Effect of tailored, daily feedback with lifestyle self-monitoring on weight loss: The SMARTER randomized clinical trial. Obesity (Silver Spring) 2022 Jan;30(1):75-84. [CrossRef] [Medline]
  38. Jakicic JM, Clark K, Coleman E, Donnelly JE, Foreyt J, Melanson E, American College of Sports Medicine. American College of Sports Medicine position stand. Appropriate intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc 2001 Dec;33(12):2145-2156. [CrossRef] [Medline]
  39. Wadden TA, Berkowitz RI, Sarwer DB, Prus-Wisniewski R, Steinberg C. Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial. Arch Intern Med 2001 Jan 22;161(2):218-227. [CrossRef] [Medline]
  40. Thomas JG, Bond DS, Raynor HA, Papandonatos GD, Wing RR. Comparison of Smartphone-Based Behavioral Obesity Treatment With Gold Standard Group Treatment and Control: A Randomized Trial. Obesity (Silver Spring) 2019 Apr;27(4):572-580 [FREE Full text] [CrossRef] [Medline]
  41. Franz MJ, VanWormer JJ, Crain AL, Boucher JL, Histon T, Caplan W, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007 Oct;107(10):1755-1767. [CrossRef] [Medline]
  42. Spring B, Pellegrini CA, Pfammatter A, Duncan JM, Pictor A, McFadden HG, et al. Effects of an abbreviated obesity intervention supported by mobile technology: The ENGAGED randomized clinical trial. Obesity (Silver Spring) 2017 Jul;25(7):1191-1198 [FREE Full text] [CrossRef] [Medline]
  43. Patel ML, Hopkins CM, Brooks TL, Bennett GG. Comparing Self-Monitoring Strategies for Weight Loss in a Smartphone App: Randomized Controlled Trial. JMIR Mhealth Uhealth 2019 Feb 28;7(2):e12209 [FREE Full text] [CrossRef] [Medline]
  44. Turner-McGrievy G, Tate D. Tweets, Apps, and Pods: Results of the 6-month Mobile Pounds Off Digitally (Mobile POD) randomized weight-loss intervention among adults. J Med Internet Res 2011 Dec 20;13(4):e120 [FREE Full text] [CrossRef] [Medline]
  45. Block G, Azar KM, Romanelli RJ, Block TJ, Hopkins D, Carpenter HA, et al. Diabetes Prevention and Weight Loss with a Fully Automated Behavioral Intervention by Email, Web, and Mobile Phone: A Randomized Controlled Trial Among Persons with Prediabetes. J Med Internet Res 2015 Oct 23;17(10):e240 [FREE Full text] [CrossRef] [Medline]
  46. Littman AJ, Boyko EJ, McDonell MB, Fihn SD. Evaluation of a weight management program for veterans. Prev Chronic Dis 2012;9:E99 [FREE Full text] [CrossRef] [Medline]
  47. Glasgow RE, Nelson CC, Kearney KA, Reid R, Ritzwoller DP, Strecher VJ, et al. Reach, engagement, and retention in an Internet-based weight loss program in a multi-site randomized controlled trial. J Med Internet Res 2007 May 09;9(2):e11 [FREE Full text] [CrossRef] [Medline]
  48. Eysenbach G. The law of attrition. J Med Internet Res 2005 Mar 31;7(1):e11 [FREE Full text] [CrossRef] [Medline]
  49. Amagai S, Pila S, Kaat AJ, Nowinski CJ, Gershon RC. Challenges in Participant Engagement and Retention Using Mobile Health Apps: Literature Review. J Med Internet Res 2022 Apr 26;24(4):e35120 [FREE Full text] [CrossRef] [Medline]
  50. Tate DF, Wing RR, Winett RA. Using Internet technology to deliver a behavioral weight loss program. JAMA 2001 Mar 07;285(9):1172-1177. [CrossRef] [Medline]
  51. West D, Krukowski R, Stansbury M, Ogden D, Borden J, Harvey J. Examining weekly facilitated group sessions and counselor‐crafted self‐monitoring feedback on treatment outcome in digital weight control: A pilot factorial study. Obesity Science & Practice 2022 Jan 05:A [FREE Full text] [CrossRef]
  52. DiClemente CC, Marinilli AS, Singh M, Bellino LE. The role of feedback in the process of health behavior change. Am J Health Behav 2001;25(3):217-227. [CrossRef] [Medline]
  53. Bidargaddi N, Almirall D, Murphy S, Nahum-Shani I, Kovalcik M, Pituch T, et al. To Prompt or Not to Prompt? A Microrandomized Trial of Time-Varying Push Notifications to Increase Proximal Engagement With a Mobile Health App. JMIR Mhealth Uhealth 2018 Nov 29;6(11):e10123 [FREE Full text] [CrossRef] [Medline]
  54. Hutchesson MJ, Tan CY, Morgan P, Callister R, Collins C. Enhancement of Self-Monitoring in a Web-Based Weight Loss Program by Extra Individualized Feedback and Reminders: Randomized Trial. J Med Internet Res 2016 Apr 12;18(4):e82 [FREE Full text] [CrossRef] [Medline]
  55. Bell K, Onyeukwu C, McClincy M, Allen M, Bechard L, Mukherjee A, et al. Verification of a Portable Motion Tracking System for Remote Management of Physical Rehabilitation of the Knee. Sensors (Basel) 2019 Feb 28;19(5):1021 [FREE Full text] [CrossRef] [Medline]
  56. Lyzwinski LN. A systematic review and meta-analysis of mobile devices and weight loss with an intervention content analysis. J Pers Med 2014 Jun 30;4(3):311-385 [FREE Full text] [CrossRef] [Medline]


CONSORT: Consolidated Standards of Reporting Trials
FB: feedback
NIH: National Institutes of Health
PA: physical activity
SBT: standard behavioral treatment
SM: self-monitoring


Edited by A Mavragani; submitted 01.04.22; peer-reviewed by M Patel, G Papandonatos; comments to author 28.04.22; revised version received 19.05.22; accepted 20.05.22; published 05.07.22

Copyright

©Lora E Burke, Susan M Sereika, Zhadyra Bizhanova, Bambang Parmanto, Jacob Kariuki, Jessica Cheng, Britney Beatrice, Maribel Cedillo, I Wayan Pulantara, Yuhan Wang, India Loar, Molly B Conroy. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 05.07.2022.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research, is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.